Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran
- 79 Downloads
Ocular toxoplasmosis, which is caused by the single-cell parasite Toxoplasma gondii, is currently the most significant cause of posterior uveitis in the world. No previous studies have described the prevalence and clinical features of ocular toxoplasmosis in the northeast of Iran. The purpose of the current study was to address this gap.
In this retrospective study, the medical records of 488 uveitis patients who presented to the Khatam-al-Anbia Eye Hospital of Mashhad University of Medical Sciences, a tertiary ophthalmology center in the northeast of Iran, between January 2013 and December 2015 were evaluated. The clinical features and risk factors of 99 (20%) consecutive patients with ocular toxoplasmosis were extracted.
Ninety-nine including 53 (53.5%) female and 46 (46.5%) male patients with ocular toxoplasmosis were included in the analysis. Reduced vision (77%) and floaters (15.2%) were the most common presenting symptoms. The age category that was most affected by ocular toxoplasmosis was 20–40 years (range: 11–65 years) with a mean age of 27.2. All patients had retinochoroiditis, but just two had anterior uveitis. All of the extracted patients, with the exception of three patients, had unilateral involvement. None of the patients had any other medical disorders with the exception of one woman, who had diabetes. Only four recurring ocular toxoplasmosis patients were referred to the education hospital during the study. Serology data were available for just 32 patients, of which 31 (96.8%) were IgG positive, and 1 (3.2%) was IgM positive.
Toxoplasma gondii was responsible for 20% of the patients of uveitis that presented to the largest ophthalmology center in the northeast of Iran. There is a high incidence of patients of ocular toxoplasmosis in the northeast of Iran, and it is a significant cause of uveitis and visual impairment in this area.
KeywordsUveitis Ocular toxoplasmosis Eye Mashhad Posterior uveitis Retinochoroiditis
Financial support for this study was provided by Mashhad University of Medical sciences financially supported this study (Project grants: 940902). The sponsor had no role in the design or conduct of this research.
Aliakbar Shamsian and Seyedeh Maryam Hosseini were involved in study concept and design and critical revision of the manuscript. Karim Sharifi helped in analysis and interpretation of data. Elham Moghaddas contributed to compilation of the manuscript. Malihe Dadgar helped in statistical analysis.
Compliance with ethical standards
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
For this type of study formal consent is not required.
- 10.Holland GN, O’Connor GR, Junior Belfort R, Remington JS (1996) Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection and immunity. Mosby, St. Louis, pp 1183–1223Google Scholar
- 13.Fallah E, Mahami L, Javadzadeh A, Mahami M, Hamzavi F, Monajjem H (2013). Study of 191 patients eye toxoplasmosis referring to hospital Tabriz—Iran. In: The 6th international and 11th national congress on quality improvement in clinical laboratory, Tehran, IranGoogle Scholar
- 26.Sheth DS, Kulkarni P, Natarajan S (2016) A case series of retinochoroidal toxoplasmosis from Western India: guide to salient features, diagnosis and treatment. J Appl Biosci 3(1):A5–A11Google Scholar